Valuation: Krka, d. d.

Market Cap 7.91B 9.03B 7.29B 6.74B 12.77B 861B 12.98B 87.19B 34.17B 425B 33.88B 33.14B 1,459B P/E 2026 *
19.1x
P/E 2027 * 18.1x
Enterprise Value 7.23B 8.25B 6.67B 6.16B 11.67B 787B 11.86B 79.69B 31.23B 388B 30.97B 30.29B 1,334B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.13x
Free-Float
65.59%
Yield 2026 *
3.48%
Yield 2027 * 3.84%
1 day-0.76%
1 week+0.38%
Current month+4.19%
1 month+2.15%
3 months+8.98%
6 months+21.96%
Current year+28.57%
1 week 260
Extreme 260
265
1 month 249.5
Extreme 249.5
267.5
Current year 202
Extreme 202
267.5
1 year 174
Extreme 174
267.5
3 years 100
Extreme 100
267.5
5 years 80
Extreme 80
267.5
10 years 48.01
Extreme 48.01
267.5
Manager TitleAgeSince
Chief Executive Officer 70 2004-12-31
Director of Finance/CFO - 1996-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 2008-12-31
Director/Board Member 59 2004-12-31
Director/Board Member 59 2004-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%+0.38%+33.16%+123.08% 9.04B
-0.17%+1.61%+16.42%+85.22% 48.69B
+1.04%-1.02%+69.47%+115.88% 36.38B
-0.13%-1.29%-2.60%+41.58% 12.19B
-0.71%+0.89%+18.28%+97.87% 12.04B
-0.86%+0.37%+52.61%-3.54% 7.06B
+0.75%-0.82%+17.49%+44.79% 7.09B
+0.69%+3.25%+19.90%+243.91% 6.75B
+5.45%-7.36%-17.93%+13.17% 6.1B
+1.24%+0.67%+29.22%+138.06% 4.38B
Average +0.65%-0.31%+23.60%+90.00% 14.97B
Weighted average by Cap. +0.37%+0.11%+29.81%+92.08%

Financials

2026 *2027 *
Net sales 2.17B 2.47B 2B 1.84B 3.5B 236B 3.55B 23.88B 9.36B 116B 9.28B 9.08B 400B 2.3B 2.62B 2.12B 1.96B 3.71B 250B 3.77B 25.34B 9.93B 123B 9.85B 9.63B 424B
Net income 420M 479M 387M 357M 678M 45.69B 689M 4.63B 1.81B 22.53B 1.8B 1.76B 77.45B 442M 504M 408M 376M 713M 48.1B 725M 4.87B 1.91B 23.72B 1.89B 1.85B 81.53B
Net Debt -680M -776M -627M -579M -1.1B -74.04B -1.12B -7.5B -2.94B -36.51B -2.91B -2.85B -125B -708M -808M -653M -603M -1.14B -77.06B -1.16B -7.8B -3.06B -38B -3.03B -2.97B -131B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,204
Date Price Change Volume
26-07-10 €261.00 -0.76% 8,143
26-07-09 €263.00 +0.38% 3,515
26-07-08 €262.00 -0.76% 7,397
26-07-07 €264.00 +1.15% 2,220
26-07-06 €261.00 +0.38% 1,253
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
261.00EUR
Average target price
242.65EUR
Spread / Average Target
-7.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock